Browse by category

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

Ascletis Pharma has revealed in a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg,...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

5 hours ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

6 hours ago

Racial and ethnic groups face barriers to obtaining OMMs

6 hours ago

Weekly Digest